In addition to chronic disease, polypharmacy is one of the most significant risks for clinical declines and hospital readmissions. An increasing number of elderly patients are taking multiple medications for a combination of disease processes, particularly to include those for chronic diseases and their common co-morbidities. This common scenario then increases the chances of critical drug interactions and serious side effects. Medications are often prescribed by different medical specialists, who may not have the opportunity to communicate with one other.
This course will cite case studies and resources such as the American Geriatric Society’s Beers Criteria and other key evidence-based practice resources, to review the dangers of polypharmacy. Then, strategies will be reviewed to best manage those clinical cases where multiple diagnoses co-exist, which often result in multiple medications.
This seminar-on-demand is 1 contact hours in length (check your state’s approval status in the state specific course catalog for your profession).
|State||Discipline||Approval Status||Provider Code||Expiration Date|
- Beers Criteria- Review and share examples from the following sections:
- Tertiary Tricyclic Antidepressants
- All antipsychotic drugs
- Non-Steroidal Anti-inflammatory Drugs (NSAIDs),
- Drugs for the following conditions:
- Heart Failure
- Chronic Constipation
- Review reasons for negative consequences:
- Higher risk of adverse drug reactions
- Decline in medication efficacy
- Reduced compliance
- Research of Polypharmacy showing increased risk of
- Adverse drug events (ADEs)
- Medication non-adherence
- Reduced functional capacity
- Multiple geriatric syndromes
- Functional decline
- Cognitive Impairment
- Fall risks
- Review age elated changes in kidney function,metabolism, liver function, cardiac output and elimination
- Studies depicting how the aging process may result in Loss of muscle mass & increase in Percentage of body fat
- Research showing how altered pharmacokinetics & pharmaco- dynamics increase the risk for both drug-drug and drug-disease interactions. (Fulton, 2005)
- Reference to the Beers Criteria from the American geriatric Society.
- Review Evidence-Based guidelines
Course Goals & Objectives:
This course is intended to instruct the professional on the case studies and resources to review the dangers of polypharmacy
- List 4 medications listed in the Beers Criteria that may be inappropriate For elderly.
- List 3 research based factors relating polypharmacy to negative clinical consequences.
- Describe how aging significantly affects drug clearance.
- List 4 recommendations made, regarding how a healthcare professional could help their older patients.
Criteria for Completion:
A score of 70% or more is considered passing. Scores of less than 70% indicate a failure to understand the material and the test will need to be taken again until a passing score has been achieved.
Contact Hours: 1
Target Audience: Physical Therapist, Physical Therapist Assistant, Occupational Therapist, Occupational Therapist Assistant, Speech Language Pathologist and Nursing
Instructional Level: Intermediate
Course Type: Seminar-on-demand
The course materials for this webinar are available in our online format.
This course is offered for 0.10 ASHA CEUs (Intermediate level, Professional area).
Financial – Lisa Milliken is employed by Windsor Rehab and receives a salary. She receives royalty payments from HomeCEUConnection.com for the presentation of this course.
Nonfinancial - no relevant nonfinancial relationship exists..
Content Disclosure: This course does not focus solely on any specific product or service.
Cancellation Policy: For activity cancellation, returns, or complaint resolution, please contact Anne Osborn by email Anne@HomeCEU or by phone at 1.800.55.4CEUS (2387). We have a 100% satisfaction guarantee. Refunds will be issued for courses that have not been completed (exam not taken), or for any course that has been rejected by your board of approval. Webinar attendance must be canceled 24 hours before the scheduled start time.